Patent · US Active

Treatments for resistant acne

US10071103B2 · kind B2 · utility

12Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2015
Grant dateSep 11, 2018
Priority date
Expiry dateJan 29, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.